Paula Bilica, DO
Obstetrics & Gynecology · San Antonio, TXNPI 1467620260
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Pacira Pharmaceuticals Incorporated accounts for 88.8% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2024 at $20,264 and has fallen 61.1% since, to $7,884 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $137.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$37K
- AbbVie$2K
- Daiichi Sankyo Inc.$639
- Mayne Pharma Commercial LLC$560
- Organon$235
- Astellas Pharma US Inc$178
- plus $1K from 28 others
What the payments were for
- Consulting fees$20,67050%
- Speaking & faculty fees$9,43523%
- Travel & lodging$5,71814%
- Food & beverage$5,42113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 52 | $36,617 |
| AbbVie(2 entities) | 74 | $1,516 |
| Daiichi Sankyo Inc. | 33 | $639 |
| Mayne Pharma Commercial LLC | 26 | $560 |
| Organon | 17 | $235 |
| Astellas Pharma US Inc | 10 | $178 |
| Pfizer | 10 | $141 |
| Myovant Sciences Inc. | 5 | $117 |
| Mylan Pharmaceuticals Inc. | 6 | $97 |
| Exeltis, USA Inc. | 5 | $94 |
| Agile Therapeutics, Inc. | 6 | $92 |
| Boston Scientific | 6 | $84 |
| Avion Pharmaceuticals | 5 | $78 |
| Myriad Women's Health, Inc. | 1 | $78 |
| Sumitomo Pharma America, Inc. | 4 | $76 |
| Merck | 5 | $74 |
| Therapeuticsmd, Inc. | 5 | $74 |
| Shield Therapeutics Inc | 4 | $69 |
| Biogen | 3 | $58 |
| Hologic Sales And Service, LLC | 1 | $51 |
| Millicent US Inc | 2 | $36 |
| Scynexis, Inc. | 2 | $33 |
| Evofem Biosciences, Inc. | 2 | $32 |
| Meditrina | 2 | $31 |
| Aspira Women's Health Inc | 2 | $25 |
| Lupin Inc. | 2 | $23 |
| Minerva Surgical, Inc | 2 | $23 |
| Coopersurgical, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Davol Inc. | 1 | $16 |
| Novo Nordisk | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Kerecis Limited | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,244 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 30 | $1,101 |
| Clobetasol Propionate | 12 | $943 |
| Nystatin | 18 | $171 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $138 |
| Fluconazole | 26 | $120 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in San Antonio
- Henry Garza IiiSan Antonio$258K
- Valentin AlmendarezSan Antonio$215K
- Camilo GonimaSan Antonio$203K
- Paulina RamirezSan Antonio$51K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.